Chen, Mingqiu
Liu, Xiaohong
Han, Chun
Wang, Xin
Zhao, Yidian
Pang, Qingsong
Sun, Xinchen
Li, Gaofeng
Zhang, Kaixian
Li, Ling
Qiao, Xueying
Lin, Yu
Chen, Junqiang http://orcid.org/0000-0003-1484-9382
Xiao, Zefen
Funding for this research was provided by:
Fujian Provincial Health & Family Planning Commissio (2016-ZQN-32)
Fujian Provincial Department of Science and Technology (2018J01306, 2017Y9079)
Fujian Provincial Platform for Medical Laboratory Research, and Key Laboratory for Tumor Individualized Active Immunity (FYKFKT- 2017015)
Article History
Received: 12 June 2019
Accepted: 12 December 2019
First Online: 15 January 2020
Ethics approval and consent to participate
: This retrospective study was approved by Fujian Province Cancer Hospital Institutional Review Board (no. K201427). All patients provided written informed consent prior to treatment, and all information was anonymized prior to analysis.
: Not applicable.
: The authors declare that they have no competing interests.